Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-24-108373

SrVP/CFO/Prin Fin & Acct Ofcr bought 450 shares at $2.61 ($1,175)

From the SEC's structured data for this filing

Trades in this filing

Hamill John P. · SrVP/CFO/Prin Fin & Acct Ofcr

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-10 Purchase : show line 1 in the form +450 $2.61 $1,175 19,318 D
Open-market purchases · 450 sh · avg $2.61 · $1,175
Loading xslF345X05/tm2426059-1_4seq1.xml…